{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:45Z","timestamp":1760057265211,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ajem.2023.02.036","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T17:28:35Z","timestamp":1677691715000},"page":"163-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Shortages of agents used to treat antimuscarinic delirium"],"prefix":"10.1016","volume":"67","author":[{"given":"James D.","family":"Whitledge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pelayia","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieran M.","family":"Glowacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin R.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryann","family":"Mazer-Amirshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2023.02.036_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15563650.2018.1485154","article-title":"Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center","volume":"57","author":"Boley","year":"2019","journal-title":"Clin Toxicol"},{"issue":"5","key":"10.1016\/j.ajem.2023.02.036_bb0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.mehy.2005.05.037","article-title":"Drugs of anesthesia acting on central cholinergic system may cause post-operative cognitive dysfunction and delirium","volume":"65","author":"Pratic\u00f2","year":"2005","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.ajem.2023.02.036_bb0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12839","article-title":"Pharmacological management of anticholinergic delirium - theory, evidence and practice: anticholinergic delirium","volume":"81","author":"Dawson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ajem.2023.02.036_bb0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1080\/15563650.2016.1245421","article-title":"2015 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 33rd annual report","volume":"54","author":"Mowry","year":"2016","journal-title":"Clin Toxicol"},{"issue":"8","key":"10.1016\/j.ajem.2023.02.036_bb0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/pds.5480","article-title":"Risk of delirium associated with antimuscarinics in older adults: a case-time-control study","volume":"31","author":"Nishtala","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.ajem.2023.02.036_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2165\/11592240-000000000-00000","article-title":"Identification and management of in-hospital drug-induced delirium in older patients","volume":"28","author":"Catic","year":"2011","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.ajem.2023.02.036_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.ajem.2023.02.036_bb0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s13181-019-00697-z","article-title":"Adverse effects of physostigmine","volume":"15","author":"Arens","year":"2019","journal-title":"J Med Toxicol"},{"issue":"2","key":"10.1016\/j.ajem.2023.02.036_bb0045","first-page":"10","article-title":"Benzodiazepine pharmacology and central nervous system\u2013mediated effects","volume":"13","author":"Iii","year":"2013"},{"key":"10.1016\/j.ajem.2023.02.036_bb0050","series-title":"Drug shortages: Implications for medical toxicology","first-page":"6","author":"Mazer-Amirshahi","year":"2015"},{"issue":"5","key":"10.1016\/j.ajem.2023.02.036_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/15563650.2020.1818768","article-title":"Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication","volume":"59","author":"Van Kernebeek","year":"2021","journal-title":"Clin Toxicol"},{"issue":"9","key":"10.1016\/j.ajem.2023.02.036_bb0060","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/15563650.2020.1869757","article-title":"Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication","volume":"59","author":"Hughes","year":"2021","journal-title":"Clin Toxicol"},{"issue":"3","key":"10.1016\/j.ajem.2023.02.036_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226836","article-title":"Donepezil: an unusual therapy for acute diphenhydramine overdose","volume":"12","author":"Ahmad","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.ajem.2023.02.036_bb0070","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.euroneuro.2017.05.006","article-title":"Treating \u2018Devil\u2019s Breath\u2019 intoxication: use of rivastigmine in six patients with toxic psychoses due to non pharmaceutical scopolamine","volume":"27","author":"Sandia","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.ajem.2023.02.036_bb0075","article-title":"Dexmedetomidine as an adjunct to treat anticholinergic toxidrome in children","volume":"4","author":"Cowan","year":"2017","journal-title":"Glob Pediatr Health"},{"key":"10.1016\/j.ajem.2023.02.036_bb0080","series-title":"Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (hyoscine)","first-page":"3","author":"Cozanitis","year":"2023"},{"issue":"4","key":"10.1016\/j.ajem.2023.02.036_bb0085","first-page":"329","article-title":"Dexmedetomidine infusion to control agitation due to anticholinergic toxidromes in adolescents, a case series","volume":"20","author":"Gee","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ajem.2023.02.036_bb0090","article-title":"Diphenhydramine-induced antimuscarinic delirium treated with physostigmine and transdermal rivastigmine","author":"Whitledge","year":"2022","journal-title":"J Med Toxicol [Internet]"},{"issue":"21","key":"10.1016\/j.ajem.2023.02.036_bb0095","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2146\/ajhp180441","article-title":"ASHP guidelines on managing drug product shortages","volume":"75","author":"Fox","year":"2018","journal-title":"Am J Health Syst Pharm"},{"year":"2012","series-title":"ACMT practice statement: Antidote shortages: Impact and response [internet]","key":"10.1016\/j.ajem.2023.02.036_bb0100"},{"year":"2020","series-title":"ACMT position statement on prescription drug shortages [internet]","key":"10.1016\/j.ajem.2023.02.036_bb0105"},{"issue":"2","key":"10.1016\/j.ajem.2023.02.036_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol Scand"},{"year":"2022","series-title":"Physostigmine salicylate injection [internet]","key":"10.1016\/j.ajem.2023.02.036_bb0115"},{"issue":"1","key":"10.1016\/j.ajem.2023.02.036_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s13181-022-00917-z","article-title":"Benzodiazepine shortages: a recurrent challenge in need of a solution","volume":"19","author":"J","year":"2023","journal-title":"J Med Toxicol"},{"issue":"3","key":"10.1016\/j.ajem.2023.02.036_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13181-020-00775-7","article-title":"ACMT position statement on prescription drug shortages","volume":"16","author":"Mazer-Amirshahi","year":"2020","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1016\/j.ajem.2023.02.036_bb0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s13181-020-00794-4","article-title":"ACMT position statement: medication administration and safety during the response to COVID-19 pandemic","volume":"16","author":"Farmer","year":"2020","journal-title":"J Med Toxicol"},{"issue":"3","key":"10.1016\/j.ajem.2023.02.036_bb0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s13181-020-00782-8","article-title":"ACMT position statement: medication shortages during coronavirus disease pandemic","volume":"16","author":"Mazer-Amirshahi","year":"2020","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.ajem.2023.02.036_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/clpt.2012.220","article-title":"Economic and technological drivers of generic sterile injectable drug shortages","author":"Woodcock","year":"2012","journal-title":"Clin Pharmacol Ther [Internet]"},{"year":"2021","series-title":"S.2595 - Drug shortages prevention and quality improvement act [internet]","key":"10.1016\/j.ajem.2023.02.036_bb0145"},{"year":"2019","series-title":"Drug shortages infographic [internet]","key":"10.1016\/j.ajem.2023.02.036_bb0150"},{"issue":"16","key":"10.1016\/j.ajem.2023.02.036_bb0155","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1056\/NEJMp1800347","article-title":"Saline shortages \u2014 many causes, no simple solution","volume":"378","author":"Mazer-Amirshahi","year":"2018","journal-title":"N Engl J Med"},{"article-title":"Committee on Security of America\u2019s Medical Product Supply Chain, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine","year":"2022","series-title":"Building resilience into the nation\u2019s medical product supply chains [internet]","key":"10.1016\/j.ajem.2023.02.036_bb0160"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723001043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723001043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:05:29Z","timestamp":1760025929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675723001043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":32,"alternative-id":["S0735675723001043"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2023.02.036","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shortages of agents used to treat antimuscarinic delirium","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2023.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}